Part 2: What impact has Brexit had on UK drug discovery?
Drug Discovery World
JULY 27, 2023
There are suggestions that pharmaceutical companies may judge it ‘not to be worth the effort to seek UK approval’, on account of the size of the national market (the UK makes up 2.4% As such, nearly 70% of new drugs authorised by UK authorities relied upon the EU’s approval process.
Let's personalize your content